40 patients were involved in this study. 20 patients received 100 mg coenzyme Q10 twice a day in combination with a standard sepsis therapy. The other 20 patients received only the standard sepsis therapy. This study showed decreased inflammation markers and a lower death rate in the test group if the micronutrient supplementation was administered in an early stage of the disease and in addition to the standard therapy of sepsis. Further details can be found in the study.


Soltani et al.


Link to article >>